Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Equity Average (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Equity Average readings, the most recent being $88.3 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 18.95% to $88.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $88.3 million, a 18.95% decrease, with the full-year FY2025 number at $100.1 million, down 20.18% from a year prior.
  • Equity Average hit $88.3 million in Q4 2025 for Treace Medical Concepts, down from $93.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $153.8 million in Q2 2023 to a low of $46000.0 in Q1 2021.
  • Median Equity Average over the past 5 years was $100.8 million (2021), compared with a mean of $97.5 million.
  • The widest YoY moves for Equity Average: up 195433.7% in 2022, down 35.56% in 2022.
  • Treace Medical Concepts' Equity Average stood at $95.2 million in 2021, then plummeted by 35.56% to $61.4 million in 2022, then soared by 124.72% to $137.9 million in 2023, then fell by 21.03% to $108.9 million in 2024, then fell by 18.95% to $88.3 million in 2025.
  • The last three reported values for Equity Average were $88.3 million (Q4 2025), $93.4 million (Q3 2025), and $101.5 million (Q2 2025) per Business Quant data.